NCT00098046View on ClinicalTrials.gov

Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

July 31, 2007

Conditions
ChickenpoxHerpes Zoster
Interventions
DRUG

famciclovir

Trial Locations (5)

10032

Columbia University Medical Center, New York

Unknown

Novartis Investigational Site, San José

Novartis Investigational Site, Cuidad de Guatemala

Novartis Investigational Site, David, Chiriqui

Novartis Investigational Site, Panama City

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00098046 - Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection | Biotech Hunter | Biotech Hunter